Pediatric Blood & Cancer
The Lived Experience of Childhood Cancer Survivors and Their Parents: A Multi-National Study of Access to Survivorship Care and Information and Support Needs HQ Cancer Team
Article
18 Feb 2025
23 Jan 2025
The object of this mid-term evaluation, as requested by Member States through decision WHA74(11), was to assess the new operating model of the GCM/NCD launched in 2022 under its 2022–2025 workplan and building upon the 2020 final evaluation of the GCM covering the period 2014–2020 and the earlier 2018 preliminary evaluation of the GCM/NCD. The evaluation focuses on progress, achievements, challenges and recommendations for enhancing GCM/NCD’s role in advancing multisectoral and multistakeholder engagement for the prevention and control of NCDs.
This evaluation covers the period from 2022 to 2024.